Redefining AAV manufacturing: a 30-minute Live30 on Sept 30

Preview text: Artis BioSolutions 96 Live case study data from Devan Puhl, PhD. Sept 30, 8:00 AM PDT /…

Thursday, Sep 24, 2026 at 6:07 PM EasternHubSpot

Landmark BioRedefining AAV manufacturing: a 30-minute Live30 on Sept 30

Fit to screenFull size

Using this email in an article? Credit: Landmark Bio email via They Sent It, with a link to this page. Full-size image

Use this example

Subject: Redefining AAV manufacturing: a 30-minute Live30 on Sept 30
Preview text: Artis BioSolutions 96 Live case study data from Devan Puhl, PhD. Sept 30, 8:00 AM PDT /…
From: contact=artisbiosolutions.com@bf07x.hs-send.com
Brand: Landmark Bio
ESP: HubSpot
Sent: Thu Sep 24, 2026, 6:07 PM ET
Size: 90 KB
Images: 8
Links: 31, 1 of them buttons
Subject length: 59 characters

Email headers

What the brand's servers put on this email. Our receiving servers, the address we subscribed with and unsubscribe links are left out.

Other sending headers (names only): X-HS-Cid, X-Report-Abuse-To

Sent just before and after

	Oct 20, 2026 7:04 AM	Live today at 11 AM ET: Viral Vector for Rare and Ultra-Rare Disease
	Oct 19, 2026 11:25 AM	Webinar Oct 20: Viral Vector Manufacturing for Rare and Ultra-Rare Disease
	Oct 2, 2026 5:46 PM	Kate E. Broderick, Ph.D. on What Synthetic DNA Removes
	Sep 29, 2026 5:37 PM	Where to find us in October
	Sep 24, 2026 6:07 PM	Redefining AAV manufacturing: a 30-minute Live30 on Sept 30 (this email)
	Jul 28, 2026 1:46 PM	An Update on Our Company Name — Introducing Artis BioSolutions
	Jul 14, 2026 4:47 PM	New Landmark Lens: Why direct biology experience matters most